
Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studies affirming the performance of one of its products. The Texas-based company builds non-invasive diagnostics for lung cancer.
What To Know: bioAffinity Technologies’s stock jumped almost 90% following the positive announcement, according to Benzinga Pro.